BioNTech SE Sponsored ADR (BNTX) vs Genmab A/S Sponsored ADR (GMAB)

BioNTech SE Sponsored ADR and Genmab A/S Sponsored ADR are both Biotechnology companies. BioNTech SE Sponsored ADR is the larger, with a market value of $24.9B against $20.8B — 1.2× the size. BioNTech SE Sponsored ADR has negative trailing earnings, so its P/E is not meaningful; Genmab A/S Sponsored ADR trades at 27.8×. Genmab A/S Sponsored ADR grew revenue faster over the last twelve months: 22.3% against −3.33%. Genmab A/S Sponsored ADR has the higher net margin (19.1% vs −65.8%) and the higher return on invested capital (6.99% vs −38.4%). Across the 19 metrics below, Genmab A/S Sponsored ADR leads on 12 and BioNTech SE Sponsored ADR on 7.